REP 2165
Alternative Names: REP 2165 magnesium chelate; REP 2165-MgLatest Information Update: 20 Aug 2024
At a glance
- Originator REPLICor
- Class Antivirals; Nucleic acids; Oligonucleotides; Polymers
- Mechanism of Action Hepatitis B virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis B; Hepatitis D
Most Recent Events
- 05 Jun 2024 Efficacy and adverse events from clinical trial in Hepatitis D presented at European Association for the Study of the Liver Congress 2024 (EASL-2024)
- 23 Mar 2023 Discontinued - Phase-II for Hepatitis B (Combination therapy, Treatment-naive) in Moldova (IV)
- 23 Mar 2023 Discontinued - Preclinical for Hepatitis D in Canada (IV)